KP Tissue released its financial results for the first quarter of 2026, reporting increased profitability and operational stability despite ongoing economic volatility.
The company stated that Kruger Products achieved Adjusted EBITDA of CAD 86.9 million, representing a 14.6% increase compared to the same period last year. Net income also rose to CAD 19.8 million.
According to Dino Bianco, CEO of KP Tissue and Kruger Products, the performance was mainly driven by lower pulp and warehousing costs, as well as operational improvements at the Memphis facility in the United States.
Revenue reached CAD 544.6 million, remaining relatively stable compared to 2025. The company also noted that demand for tissue products continues to remain healthy in both Canada and the United States.
In addition, the company announced an increase in its quarterly dividend to CAD 0.21 per share and confirmed the ramp-up of a new converting line in Memphis to expand production capacity in the U.S. market.
The company stated that it will continue focusing on maintaining positive operating margins amid higher fuel, freight and logistics costs.
